Genmab A/S – admittance to trading and official listing

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Genmab A/S – admittance to trading and official listing of new shares due to employee warrant exercise

The share capital of Genmab A/S has been increased. The admittance to trading and official listing will take effect as per 30 September 2016 in the ISIN below.

ISIN: DK0010272202
Name: Genmab
Volume before change: 60,181,757 shares (DKK 60,181,757)
Change: 66,840 shares (DKK 66,840)
Volume after change: 60,248,597 shares (DKK 60,248,597)
Subscription prices: ·         875 shares at DKK 31.75 ·         2,500 shares at DKK 40.41 ·         250 shares at DKK 66.60 ·         3,600 shares at DKK 67.50 ·         250 shares at DKK 79.25 ·         900 shares at DKK 80.55 ·         90 shares at DKK 129.75 ·         1,500 shares at DKK 210 ·         100 shares at DKK 215.60 ·         6,900 shares at DKK 225.90 ·         5,625 shares at DKK 234 ·         1,000 shares at DKK 234.75 ·         1,600 shares at DKK 246 ·         2,350 shares at DKK 254 ·         9,850 shares at DKK 272 ·         1,750 shares at DKK 326.50 ·         225 shares at DKK 329 ·         2,162 shares at DKK 330 ·         19,250 shares at DKK 352.50 ·         6,063 shares at DKK 364
Face value: DKK 1
Short name: GEN
Orderbook ID: 11143

For further information, please contact: Asta Jepsen, Surveillance, tel. +45 33 93 33 66

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Eli Lilly's Pirtobrutinib Shows Promising Results in CLL Trials

Updated Category News Views 158

Pirtobrutinib's Efficacy in Chronic Lymphocytic Leukemia Studies Eli Lilly and Company (NYSE: LLY) made notable advancements in chronic lymphocytic leukemia (CLL) research with their drug, pirtobrutinib. The recent study, known as BRUIN CLL-321, demonstrated that pirtobrutinib significantly reduced the risk of disease progression or death by 46% compared to previous...

Continue Reading
Exploring Axon Enterprise's Options Trading Dynamics

Updated Category News Views 173

Investors' Insights on Axon Enterprise In the ever-evolving world of stock market investments, insights from institutional and wealthy individual investors can carry significant weight. Recently, there has been a noticeable bullish stance on Axon Enterprise (NASDAQ: AXON), raising curiosity among retail traders about potential future movements. Unusual Options Activity...

Continue Reading
Aventis Energy Releases Technical Report on Corvo Project

Updated Category News Views 143

Aventis Energy Files NI 43-101 Technical Report on Corvo Project Aventis Energy Inc. (“Aventis” or the “Company”) (CNSX: AVE | Frankfurt: C0O0 | Other OTC: VBAMF) is excited to announce that its partner, Standard Uranium Ltd., has filed a technical report detailing findings and exploration data from the Corvo Project. This report, titled "Technical Report on the...

Continue Reading
Drucker + Falk Celebrates Community Commitment Through Cleanup Events

Updated Category News Views 108

Drucker + Falk's Dedication to Community Engagement Drucker + Falk, a prominent name in multifamily property management, has made remarkable strides in community involvement through its annual clean-up initiatives. This year, they marked the third consecutive clean-up campaign aimed at enhancing local environments, aligning their efforts with the mission of Keep America...

Continue Reading
Exploring the Future of Mental Health: The Wholeness Center

Updated Category News Views 96

Revolutionizing Mental Health with Integrative Approaches The Wholeness Center has gained state approval to offer legal psilocybin-assisted therapy, marking a significant milestone as the sole licensed healing center in Northern Colorado. This innovative facility combines the realms of psychedelic therapy with integrative psychiatry, aiming to provide comprehensive mental...

Continue Reading